Portland, OR - January 21, 2017

(Co-hosted by SolSurvivors Oregon and OHSU Department of Dermatology)

Date: Saturday – January 21, 2017
Time:  8:30am – 1:00pm PST
Collaborative Life Sciences Building
Room 3A001
2730 SW Moody Ave
Portland, OR 97201

Remote viewing parties will also be held at:

Knight Cancer Institute Regional Outreach Office
963 SW Simpson Ave, Suite 100
Bend, OR 97702

Samaritan Pastega Regional Cancer Center
501 NW Elks Drive
Corvallis, OR 97330

Watch from your computer at home!
Please join us for the live streaming of the event starting at 9:00am PST by clicking here.


Information about the Collaborative Life Sciences Building
CLSB is located at the west end of the Tilikum bridge.
The MAX Orange line stops directly in front of the CLSB.

To learn more about SolSurvivors Oregon click here.

Presenters and Topics



Coffee and bagels provided


Welcome and Overview
Katie Wilkes
SolSurvivors Oregon

Alicia Rowell
AIM at Melanoma


Turning Community-Identified Needs Into a Research Project
SolSurvivors Community Engagement Committee panel


Melanoma Prevention and Self-Skin Exams
Sancy Leachman, MD, PhD Chair of the Department of Dermatology
Director of the Melanoma Program
OHSU Knight Cancer Institute


Discussions in Small Groups


Participants will be moving downstairs.
Box lunches will be provided.


Keynote: Melanoma Treatment Update
- Current direction of melanoma clinical trials in the US
· The basic science behind the main therapies
· How patients can be engaged in their care in the setting of rapidly expanding melanoma therapies
Omid Hamid, MD
Director of the Melanoma Center and Phase I Immuno-Oncology Program
The Angeles Clinic and Research Institute




Q&A with Melanoma Experts

Walter Urba, MD, PhD
Director of the Cancer Research
Earle A. Chiles Research Institute
Providence Cancer Center

Oliver Wisco, DO, FAAD, FACMS
Mohs Surgeon, Melanoma Specialist & General Dermatologist
Bend Memorial Clinic

Brendan Curti, MD
Director of Genitourinary Oncology Research and the Immunotherapy Clinical Program
Co-Director of the Melanoma Program
Providence Cancer Center

Matt Taylor, MD
Program Director
OHSU Knight Cancer Institute phase 1 clinical trials

Kristin Massimino, MD
Surgical oncologist

Carlo Bifulo, MD
Medical Director of Oncological Molecular Pathology and Pathology Informatics
Providence Oregon Regional Laboratory
Director of Translational Molecular Pathology
Earle A. Chiles Research Institute



Other Information

Bagels and coffee will be provided during Registration.
Lunch will also be provided.
If you have any questions, please email sguild@AIMatMelanoma.org.

Please keep me informed.

Receive comprehensive, breaking news about melanoma, research, legislation, and events.

  • This field is for validation purposes and should be left unchanged.